Polio vaccination drive in Kayin, Mon, and Bago - Myanmar Times

Polio vaccination drive in Kayin, Mon, and Bago - Myanmar Times

Polio vaccination drive in Kayin, Mon, and Bago - Myanmar Times

Posted: 04 Jul 2019 12:00 AM PDT

The programme from July 7 to 11 will cover seven townships in Kayin, three in Mon, and two in Bago, according to a statement by the Ministry of Health and Sports. 

The vaccinations will cover children under 15 only in Hpapun township, Kayin, and those under five in the other 11 townships. It is estimated that 300,000 youngsters will receive the polio vaccines.

"Vaccine-derived poliovirus type 1, or VPDP1, can infect children who have never been inoculated with the polio vaccine, so every child absolutely needs to take part in the vaccination programme," Htar Htar Linn, programme manager of the department's Extended Programme on Immunisation said.

The vaccination campaign was ordered after a child in Sin Swel village near Hpapun township, Kayin, was found to have contracted the VPDP1 virus in June. The virus was confirmed by testing at Myanmar's National Health Laboratory and the Specialised Polio Laboratory in Mumbai, India, on June 23.

A field investigation team with representatives from the department's Contagious Disease Prevention and Extended Programme on Immunisation, the National Health Laboratory, Yangon Children's Hospital, the Public Health University, the World Health Organization, and the United Nations Children's Fund conducted studies in Hpapun from June 24 to 26. 

According to the findings of the investigation team, there has been no polio vaccination programme in 249 out of 313 villages in Hpapun due to armed conflicts in the area. 

According to the Global Polio Eradication Initiative, vaccine-derived polioviruses are a rare strain of poliovirus that have genetically mutated from the strain contained in the oral polio vaccine. The oral polio vaccine contains a live, attenuated (weakened) vaccine-virus. 

When a child is vaccinated, the weakened vaccine-virus replicates in the intestine and enters into the bloodstream, triggering a protective immune response in the child, providing immunity to polio. Like wild poliovirus, the child excretes the vaccine-virus for a period of six to eight weeks.

Comments

Post a Comment

Popular posts from this blog

Roseola vs. measles rash: What is the difference? - Medical News Today

Image
Roseola and measles are two different diseases that present with a high fever and a rash. They are both most commonly seen in childhood, although measles can affect people of any age, and roseola in adults is very rare. While both diseases share similarities, there are distinguishing factors, such as how the symptoms present and the disease progression. Read on to find out the difference between roseola and measles rashes. Roseola, also known as roseola infantum, sixth disease, or exanthema subitum, is a viral infection that typically affects children. The human herpesvirus 6 (HHV-6) or human herpesvirus 7 (HHV-7) causes roseola. The disease is spread through tiny respiratory droplets that people either breathe in or pick up from surfaces they touch. This disease usually presents in children between the ages of 6–12 months . Children who have this disease experience a high fever, followed by a pink or red rash. Roseola is a self-limiting viral illness, meaning it will typically go awa...
Read more

poliomyelitis treatment

Image
poliomyelitis treatment Drug and Device News March 2019 - P&T Community Posted: 04 Mar 2019 10:35 AM PST NEW DRUG APPROVALS Ontruzant, a Herceptin Biosimilar The FDA has approved trastuzumabdttb (Ontruzant, Samsung Bioepis Company, Ltd.) for HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma. Trastuzumabdttb, a HER2/neu receptor antagonist, is the third FDA-approved biosimilar of Herceptin (Genentech). Patients should be selected for therapy based on an FDA-approved companion diagnostic. Trastuzumab-dttb carries a boxed warning about the risks of cardiomyopathy, serious and fatal infusion reactions, embryo-fetal toxicity, and pulmonary toxicity. Ontruzant will be marketed and distributed in the U.S. by Merck. Sources: Samsung Bioepis, January 21, 2019; Ontruzant . prescribing information, January 2019; FDA, January 18, 2019 Vaxelis, a Combination Vaccine T...
Read more

Coronavirus fake news echoes century-old polio fears - Newsroom

Image
Coronavirus fake news echoes century-old polio fears - Newsroom Coronavirus fake news echoes century-old polio fears - Newsroom Posted: 05 Feb 2020 08:32 AM PST FEBRUARY 6, 2020 Updated 15 hours ago Dr Heather Battles Dr Heather Battles is a lecturer in anthropology at the University of Auckland and researches infectious diseases and epidemics. Show more Ideasroom During the past month, in the confusion and uncertainty over the precise origin of the 2019 novel coronavirus outbreak, many alternate ideas or 'conspiracy theories' have sprung up and spread widely via social media including Twitter and Facebook. I have had a sense of déjà vu as many of these claims have parallels in how people responded to another 'emerging' epidemic disease a century ago: polio. The first example that struck me is the idea (spread by US fake news website Infowars and others) that the roll-out of 5G technology is to blame, wit...
Read more